Write to the Editor at publications@topra.org
HM1: General pharmaceutical legislation – Platform technology and sandbox approaches
By Evyenia Shaili
HM2: Fireside chat
By Cristina Dragan
HM3: Applying Artificial Intelligence in real life
By Natasha Bankowski
HM4: Revision of the EU Variation Regulation – Continuing innovation in lifecycle management
By Jessica Roe
HM5/MD1/IVD1: Programme COMBINE – Accelerating clinical trials and medical innovation in the EU
By Nathalie Boeglin
HM6: How Artificial Intelligence is transforming regulatory approaches towards chemistry, manufacturing and controls (CMC)
By Francisco Baptista
HM7: First experiences with the HTA Regulation
By Andrea Laslop
HM8: ePI is on FHIR – Preparing for implementation
By Frank Vandendriessche
HM9: From barrier to bridge – Practical strategies for successful advanced therapy medicinal product (ATMP) development
By Bruno Speder
HM10: Strengthening Europe’s clinical trials competitiveness
By Nathalie Boeglin
No comments yet